海森药业

001367 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

3.3B ($483.3M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

472.0M

Net Income

123.0M

Gross Margin

N/A

Op. Margin

30.1%

Net Margin

26.1%

ROE

9.2%

ROA

8.3%

D/E

0.11

Dividend Yield

N/A

EPS

1.21

Current Ratio

10.31

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, sale, and import and export of pharmaceutical intermediates, active pharmaceutical ingredients, and preparations in China and internationally. The company offers active pharmaceutical ingredients for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, cardiovascular, antispasmodic, antibacterial agent, histamines drug, and anticonvulsant. It also provides chemical products for intermediates and food additives. Zhejiang Haisen Pharmaceutical Co., Ltd. was founded i...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 海森药业

Ticker	001367
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业